Netherlands Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2007

  1. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones

    Drug Metabolism and Disposition, Vol. 35, Núm. 10, pp. 1873-1879

  2. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

    Molecular and Cellular Biology, Vol. 27, Núm. 4, pp. 1247-1253

2006

  1. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion

    Drug Metabolism and Disposition, Vol. 34, Núm. 4, pp. 690-695

  2. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk

    Carcinogenesis, Vol. 27, Núm. 1, pp. 123-130

2005

  1. Human cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine

    Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 1, pp. 144-152

  2. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

    Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1765-1771

  3. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin

    Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1758-1764

  4. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk

    Nature Medicine, Vol. 11, Núm. 2, pp. 127-129

  5. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)

    Drug Metabolism and Disposition, Vol. 33, Núm. 5, pp. 614-618